What question did this study set out to answer?

This research aims to design small-molecule inhibitors targeting anti-apoptotic Bcl-2 proteins to induce cancer cell death.

Structure-Based Design of Potent Small-Molecule Inhibitors of Anti-Apoptotic Bcl-2 Proteins

View Full Paper

Ask AI

Bookmark

This research aims to design small-molecule inhibitors targeting anti-apoptotic Bcl-2 proteins to induce cancer cell death.
Structure-based design of inhibitors targeting Bcl-2, Bcl-xL, and Mcl-1.
Testing binding affinities using K(i) values.
Evaluating inhibition of cell growth and apoptosis induction in PC-3 prostate cancer cells.
Compound 5 (TW-37) binds to Bcl-2 with a K(i) of 290 nM and shows high affinity for Bcl-xL and Mcl-1.
IC(50) for compound 5 is 200 nM, indicating potent inhibition of cell growth.
Compound 5 induces apoptosis in a dose-dependent manner.

No takes yet. Share an insight, caveat, or question.

Randomized trial demonstrates potent inhibition of cell growth in prostate cancer using new Bcl-2 inhibitors, highlighting therapeutic potential.

Wang et al. (2006) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial demonstrates potent inhibition of cell growth in prostate cancer using new Bcl-2 inhibitors, highlighting therapeutic potential.